Raymond F. Schinazi
0000-0002-6688-3614
Publication & Citation Trends
Publications
0 total
Botanical inhibitors of SARS-CoV-2 viral entry: a phylogenetic perspective OA
Cited by 8
Semantic Scholar
Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies OA
Cited by 42
Semantic Scholar
Enriched zones of embedded ribonucleotides are associated with DNA replication and coding sequences in the human mitochondrial genome
Cited by 1
Semantic Scholar
N4-Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness OA
Cited by 3
Semantic Scholar
TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques OA
Cited by 21
Semantic Scholar
Synthesis and evaluation of highly potent HBV capsid assembly modulators (CAMs). OA
Cited by 8
Semantic Scholar
Synthesis of 4′-Substituted Carbocyclic Uracil Derivatives and Their Monophosphate Prodrugs as Potential Antiviral Agents OA
Cited by 4
Semantic Scholar
Vpx requires active cellular dNTP biosynthesis to effectively counteract the anti-lentivirus activity of SAMHD1 in macrophages OA
Cited by 3
Semantic Scholar
Research Topics
HIV/AIDS drug development and treatment
(428)
HIV Research and Treatment
(272)
Biochemical and Molecular Research
(155)
Hepatitis C virus research
(142)
Hepatitis B Virus Studies
(105)
Affiliations
Université de Technologie de Compiègne
Southern Research Institute
Boston University
Buffalo State University
University of Hawaiʻi at Mānoa